METTL3 and leukemia: More importantly, STM2457 attenuated the growth of leukemia cells and promoted their differentiation as well as apoptosis in vitro, and the METTL3 inhibitor prolonged the survival of leukemia mice models by impairing leukemia cell engraftment and suppressing leukemic stem cell subpopulations.